Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Imported vs Marketed Probucol in Healthy Chinese Volunteers
NCT02196805Phase 1Completed
- Sponsor
- Otsuka Holdings
- Start
- Mar 2009
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of probucol in hypercholesterolemia (2 arms), sponsored by Otsuka Holdings. Primary endpoints: Area Under the Concentration-Time Curve from Time Zero to Last Quantifiable Concentration and Maximum Plasma Concentration. Started Mar 2009; status: completed.
02
Drugs
probucol
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02196805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02196805.